探討運用酪氨酸激酶受體抑制劑 Sitravatinib 以及 Erdafitinib 來增加有 ABCB1 或 ABCG2 過度表現之多重抗藥性癌細胞對常規化療藥物的感受性

Translated title of the contribution: Investigating the chemosensitization effect of tyrosine kinase inhibitors sitravatinib and erdafitinib on ABCB1- and ABCG2-overexpressing multidrug-resistant cancer cells

余依柔

Research output: Types of ThesisMaster's thesis

Translated title of the contributionInvestigating the chemosensitization effect of tyrosine kinase inhibitors sitravatinib and erdafitinib on ABCB1- and ABCG2-overexpressing multidrug-resistant cancer cells
Original languageChinese (Traditional)
Supervisors/Advisors
  • Wu, Chung-Pu, Supervisor
StatePublished - 2020
Externally publishedYes

Cite this